New Ikarugamycin Derivatives with Antifungal and Antibacterial Properties from Streptomyces zhaozhouensis

Rodney Lacret,Daniel Oves-Costales,Cristina Gómez,Caridad Díaz,Mercedes de la Cruz,Ignacio Pérez-Victoria,Francisca Vicente,Olga Genilloud,Fernando Reyes
DOI: https://doi.org/10.3390/md13010128
2014-12-29
Marine Drugs
Abstract:A bioassay guided fractionation of the ethyl acetate extract from culture broths of the strain Streptomyces zhaozhouensis CA-185989 led to the isolation of three new polycyclic tetramic acid macrolactams (1-3) and four known compounds. All the new compounds were structurally related to the known Streptomyces metabolite ikarugamycin (4). Their structural elucidation was accomplished using a combination of electrospray-time of flight mass spectrometry (ESI-TOF MS) and 1D and 2D NMR analyses. Compounds 1-3 showed antifungal activity against Aspergillus fumigatus, Candida albicans and antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA).
pharmacology & pharmacy,chemistry, medicinal
What problem does this paper attempt to address?